stock-detail (SPPI)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

Immune Drug for Deadly Skin Cancer Shows Long-Term Survival

5/19/2016 12:01 pm

(CBS News/Associated Press) May 19, 2016 - A new kind of drug for the deadliest form of skin cancer helped some patients survive for at least three years, a study shows. It's a remarkable advance for patients who until recently faced dismal chances of living for more than a few months.

Preserving Fertility In Women Receiving Cancer Treatment

5/17/2016 01:00 pm

(The Jackson Laboratory) May 17, 2016 - Female cancer patients may be able to retain their fertility during radiation and chemotherapy through treatments that target the DNA damage response in oocytes.

AstraZeneca Asthma Drug Shows Positive Results

5/17/2016 12:02 pm

(MarketWatch/Wall Street Journal) May 17, 2016 - AstraZeneca PLC reported positive results from two late-stage studies on a severe asthma treatment that it hopes will grab market share in an increasingly competitive area.

UnitedHealth Will Drop Out Of Most ACA Exchanges

4/19/2016 02:02 pm

(Modern Healthcare) Apr 19, 2016 - UnitedHealth Group CEO Stephen Hemsley said Tuesday the health insurance and services conglomerate will pull out of most of its Affordable Care Act marketplaces. But the company won't bail on the exchanges completely and will sell individual plans in a “handful” of states.

QIAGEN Partners to Develop Novel Companion Diagnostic in Lung Cancer

4/14/2016 11:02 am

(QIAGEN) Apr 13, 2016 - Collaboration with Mirati Therapeutics targets MET gene mutations to personalize treatment.

Breast Cancer Resistance to CDK4/6 Inhibitors Arises in Many Ways

3/28/2016 11:04 am

(AACR) Mar 28, 2016 - Breast cancer cells became resistant to therapeutics targeting CDK4/6, such as palbociclib (Ibrance), in multiple ways, and preclinical studies suggested different combinations of therapeutics may prevent and overcome the acquisition of resistance to these anticancer agents, according to new research.

Foundation Medicine Announces First-Ever Public Release of Broad Pediatric Data From FoundationCORE™ to Accelerate the Development of Precision Medicine Strategies for Pediatric Cancers

2/25/2016 12:00 pm

(Yahoo! Finance) Feb 25, 2016 - Foundation Medicine, Inc. today announced that the company will release to the public molecular profiles of pediatric cancers currently maintained as part of FoundationCore™, the company’s information knowledgebase.

Sun Hopes Cut-Price Generic Gleevec Will Win Third Of U.S. Market

2/2/2016 12:00 pm

(Reuters) Feb 1, 2016 - Sun Pharma launched a generic version of Novartis's leukaemia drug Gleevec on Monday in the United States and hopes to poach a third of sales in six months by pricing the copycat some 30 percent cheaper, Sun's North American chief executive said.

BLA for Adalimumab Biosimilar Accepted for Review

1/26/2016 12:05 pm

(Monthly Prescribing Reference) Jan 26, 2016 - Amgen announced that the Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for ABP 501, a biosimilar candidate to Humira (adalimumab).

Experiment In Coordinated Care For Medicare Failed To Show Savings

7/28/2015 12:01 pm

(NPR/Shots blog) July 27, 2015 - The test aimed to help high-risk Medicare patients navigate the health care maze. But after three years, expected improvements in quality and savings failed to materialize.

U.S. Indoor Tanning Rates Are Dropping, But Still High

7/27/2015 12:00 pm

(NCI/Cancer Currents Blog) July 24, 2015 - The number of people who tan indoors appears to be dropping, according to a new study from researchers at NCI and the U.S. Centers for Disease Control and Prevention (CDC). But using indoor tanning devices such as sunlamps, sunbeds, or tanning booths, which-increases-skin-cancer-risk, is still a common practice, they reported.

Siteman Cancer Center Earns Highest Rating From Federal Cancer Institute

7/8/2015 12:00 pm

(St. Louis Post-Dispatch) July 8, 2015 - Siteman Cancer Center at Barnes-Jewish Hospital has earned the highest quality rating from the federal government’s principal agency for cancer research and training.

Increases in Cancer Screening May Reflect Removal of Financial Barriers in Affordable Care Act

6/4/2015 12:00 pm

(American Cancer Society) June 4, 2015 - Screening for colorectal cancer increased in lower socioeconomic status (SES) individuals after 2008, perhaps reflecting the Affordable Care Act's removal of financial barriers to screening according to a new analysis.

Former Rep. LaTourette Files Claim Over Missed Cancer

5/29/2015 03:01 pm

(Seattle Times/Associated Press) May 27, 2015 - Former Rep. Steve LaTourette of Ohio, gravely ill with pancreatic cancer, has filed a claim against the government over the treatment he received from his Capitol doctors.

Massive Bio Introduces Cancer Genomics Advisory Services for Community Oncologists

5/29/2015 03:00 pm

(Morningstar) May 29, 2015 - Massive Bio, a Manhattan-based startup, providing personalized advisory services for cancer patients, oncologists and oncology practices will begin offering its on-demand services publicly on June 1, following rigorous testing over the past three months.

Myriad Significantly Advances the myChoice(R) HRD(TM) Companion Diagnostic Test

5/29/2015 02:02 pm

(Myriad) May 29, 2015 - Myriad Genetics, Inc. today announced new clinical studies on its myChoice HRD companion diagnostic test at the 2015 American Society of Clinical Oncology annual meeting being held in Chicago, Ill.

Novartis Presents New Data on 21 Medicines and 11 Investigational Compounds at ASCO and EHA

5/27/2015 12:00 pm

(Novartis) May 27, 2015 - Novartis will highlight the strength of its expanded oncology portfolio in 21 medicines and 11 investigational compounds across more than 185 data presentations at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, May 29-June 2, and the Congress of the European Hematology Association (EHA), June 11-14.

Lymphoma Pattern Reassuring With Anti-TNF in RA

5/5/2015 12:02 pm

(Medpage Today/The Gupta Guide) May 5, 2015 - No change in the pattern of lymphomas was seen among patients with rheumatoid arthritis (RA) treated with biologic therapies compared with those not receiving biologics, a large collaborative European analysis showed.

ELCC 2015 News: Detection of EGFR T790M Mutation From Circulating Tumour DNA in Urine of Patients with Metastatic NSCLC

4/17/2015 11:05 am

(ESMO) Apr 17, 2015 - Monitoring circulating tumour DNA (ctDNA) is a promising technique that may provide clinicians with a faster, cheaper and less invasive way to evaluate the clinical status and response to therapy of cancer patients.

Smartwatches Might Cause Cancer, Says Article Based on ‘Expert’ Who Pushes Holistic Breast Cancer Treatments

3/20/2015 12:02 pm

(Washington Post/Speaking of Science) Mar 19, 2015 - Fitbits probably won't give people tumors, but articles like the one The New York Times ran this week might give me an ulcer.

U.K. Regulators Grant Early Access to Merck Skin Cancer Drug, but Where Is Northwest Bio?

3/11/2015 12:00 pm

(TheStreet) Mar 11, 2015 - Skin cancer patients in Britain can be treated with Merck's Keytruda before the cancer immunotherapy drug is approved there under a new early access plan announced Wednesday.

AcelRx Says FDA Calls for Additional Trial on Zalviso

3/9/2015 01:00 pm

(Wall Street Journal) Mar 9, 2015 - AcelRx Pharmaceuticals Inc. said the U.S. Food and Drug Administration is calling for an additional clinical trial to assess risk tied to its experimental pain-management treatment, further delaying its potential approval and marketing.

FDA is Sued by Otsuka For ‘Unlawfully’ Widening the Market for Abilify

3/6/2015 12:00 am

(Wall Street Journal/Pharmalot blog) Mar 26, 2015 - It’s not every day that a drug maker complains the FDA widened a market for one of its drugs.

Valeant to Buy Salix in $10.1 Billion Deal

2/23/2015 12:03 pm

(Fox Business/Reuters) Feb 23, 2015 - Canada's Valeant Pharmaceuticals International Inc agreed to acquire gastrointestinal drugmaker Salix Pharmaceuticals Ltd in an all-cash deal valued at about $10.1 billion, the two companies said on Sunday.

Looking For That Fruit or Vegetable That Might Prevent Cancer?

2/19/2015 12:00 pm

(Washington Post) Feb 16, 2015 - Only about half of the recommendations on two internationally syndicated TV medical talk shows were supported by scientific evidence, according to a recent study in the journal BMJ.